Skip to main content
. Author manuscript; available in PMC: 2013 Oct 5.
Published in final edited form as: JAMA. 2013 Apr 10;309(14):1493–1501. doi: 10.1001/jama.2013.3190

Figure 1.

Figure 1

Kaplan-Meier Survival Curves of PTC-Specific Survival by BRAF V600E Mutation Status

Comparison of patient survival, represented by log-rank P values in each panel, was performed between BRAF V600E–negative and BRAF V600E–positive groups for all patients and for patients with conventional papillary thyroid cancer (PTC). Follow-up time is truncated at 12 years.